3Settimana·

Elevance Health Q2 '25 Earnings Highlights

$ELV (+0,64%)

attachment


  • EPS: $8.84 vs $9.07 expected ❌
  • Revenue: $49.4 billion vs $48.14 billion expected ✅
  • FY25 EPS guidance: $30.00 vs $34.48 consensus ❌



  • Benefit cost ratio: 88.9%; increase of +260 basis points compared to the previous year
  • Operating expense ratio: 10.1 %; decrease of -160 basis points compared to the previous year



The second-largest health insurer reported its profits. Although these were below consensus, they were not too bad given the panic in the industry.


The benefit cost ratio was 88.9%, an increase of 260 basis points from the previous year, reflecting the trend toward higher medical costs, particularly in the Medicaid business and ACA health plans.


CEO Comment:


  • "In the second quarter, Elevance Health made significant progress in delivering a simple and personalized experience for our customers while advancing our efforts to improve efficiencies across the health system ... With the embedded earnings power of our diversified Health Benefits and Carelon businesses, we remain confident in our ability to deliver at least 12% compound annual growth in adjusted diluted earnings per share over time." - Gail K. Boudreaux


attachment


$UNH (+0,13%)
$CNC (+0,59%)
$US60855R1005 (+0,24%)
$CVS (+0,15%)
$OSCR

10
17 Commenti

immagine del profilo
3Settimana
How many shares are you up to now? There should already be a lot of skin in the game. 😁

EDIT: At UNH, of course.
1
immagine del profilo
5
3Settimana
I'm also invested at around -25%, but have a savings plan running. Let's hope you'll be right 🙏
1
immagine del profilo
1
immagine del profilo
@Hu_F_10 After all, it's an investment, sometimes it just takes time 👍
1
immagine del profilo
Great post, thank you for summarize it! Do you think is a good moment to buy ELV, now that it's cheaper?
1
immagine del profilo
@ASBaracca I would go with $UNH , but the whole sector is Not really expensive. ✌️
immagine del profilo
I've just done the same 😂
I put off buying for a long time because I wanted to see how it would develop over the weeks. I also think that most of it is already priced in 🧐
1
immagine del profilo
@Aktienhauptmeister 💪 Let's wait for the earnings, I'm pretty positive. I think $UNH has only missed earnings once since 2008 and since they had already reduced and suspended the guidance, I expect a positive surprise, you can see at $ELV that mainly Medicaid and ACA are affected, the share of sales at $UNH is lower. Above all, if they reflect negatively before the earnings, then it's more likely to be a positive surprise.
1
immagine del profilo
@BamBamInvest they will report the figures next week if I am not mistaken 🤔 I am also very positive. of course there is downside potential, but the risk/reward ratio is already more than attractive in my opinion
1
immagine del profilo
@Aktienhauptmeister Tuesday 29.07. still takes a while
1
immagine del profilo
3Settimana
I bought yesterday at € 253. I think the share has the potential to generate a hundred percent return in the coming years.
1
immagine del profilo
@Andiiiii I think 100% is the minimum, I think they will benefit from providers like <security:n/a:US60855R1005> and $CNC, which are too active in the Medicaid and ACA sector. $OSCR will also benefit from this in the long term. Developments in the healthcare sector remain exciting. Politically, there will also have to be an interim solution in the individual states because of the voters, as individual politicians (whether Republicans or Democrats) want to be re-elected. In an extreme gar phase, it doesn't hurt to move into sectors that are more conservative and have not done well so far (even if justified). The time for health insurers will come again sooner or later and a lot of negative things are already priced in. ✌️
1
immagine del profilo
2Settimana
@BamBamInvest see it exactly the same way and can only agree.✌️
1
immagine del profilo
3Settimana
I'm curious to see if it will be the same kind of bloodbath at $UNH
immagine del profilo
@GGHyperX I think this is already priced in, especially as they had already suspended and reduced their guidance. In addition, they only have half of Medicaid / ACA % sales of $ELV, you can see that it hardly rubs off. $ELV ~ 25% , United 11-15% share of sales . $UNH has also been hit harder than $ELV. I think it will be better than expected and positive, but we'll see.
Partecipa alla conversazione